Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis: A comparison with C-reactive protein

Journal of Clinical Gastroenterology

Volumn 19, Issue 2, 1994, Pages 112-117

  Pezzilli, R ^a   Billi, P ^a   Plate L ^a   Barakat, B ^a   Bongiovanni, F ^a   Miglioli, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute pancreatitis; Amylase; C reactive protein; hPSTI; Lipase

Indexed keywords

APROTININ; C REACTIVE PROTEIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM;

ABDOMEN, ACUTE; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TRYPSIN INHIBITOR, KAZAL PANCREATIC;

EID: 0028017976     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-199409000-00007     Document Type: Article

References (33)

1. Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from the pancreas. J Am Chem Soc 1948;70:304-40.
2. Kikuchi N, Nagata K, Yoshida N, Ogawa M. The multiplicity of human pancreatic secretory trypsin inhibitor. J Biochem 1985;98:687-94.
3. Greene LJ, Pubols MH, Bartlet DC. Human pancreatic secretory trypsin inhibitor. Methods Enzymol 1976;45: 813-25.
4. Pubols MH, Bartlet DC, Greene LJ. Trypsin inhibitor from human pancreas and pancreatic juice. J Biol Chem 1974;249:2235-42.
5. Klaus W, Schonburg D. Solution structure of a variant of human pancreatic secretory trypsin inhibitor determined by nuclear magnetic resonance spectroscopy. J Mol Biol 1993;229:695-706.
6. Yamamoto T, Nakamura Y, Nishide J, et al. Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitor (PSTI) cDNA. Biochem Biophys Res Commun 1985;132:605-12.
7. Ogawa M, Kitahara T, Fujimoto KI, Tanaka S, Takatsuka Y, Kosaki G. Serum pancreatic secretory trypsin inhibitor in acute pancreatitis. Lancet 1980;2:205.
8. Satake K, Inui A, Sogabe T, et al. The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease. Int J Pancreatol 1988;3:323-32.
9. Lasson A, Ohlsson K. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 1984;19:779-86.
10. Hjelmqvist B, Wattsgard C, Borgstrom A, Lasson A, Nyman U, Ohlsson K. Pathobiochemistry and early CT findings in acute pancreatitis. Digestion 1989;44:184-90.
11. Malfertheiner P, Dominguez-Munoz JE. Prognostic factors in acute pancreatitis. Int J Pancreatol 1993;14:l-8.
12. Agarwal N, Pitchumoni CS. Assessment of severity in acute pancreatitis. Am J Gastroenterol 1991;86:1385-91.
13. Viedma JA, Perez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-7.
14. Pezzilli R, Billi P, Platè L, Bongiovanni F, Morselli Labate AM, Miglioli M. Human pancreas-specific protein/procarboxypeptidase B: a useful serum marker of acute pancreatitis. Digestion 1994;55:73-7.
15. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69-81.
16. Pezzilli R, Billi P, Miglioli M, Gullo L. Serum amylase and lipase concentrations and lipase/amylase ratio in assessment of etiology and severity of acute pancreatitis. Dig Dis Sci 1993;38:1265-9.
17. Galen RS, Gambino SR. How to determine the predictive value and efficiency of a test when reading a scientific paper. In: Galen RS, Gambino SR, eds. Beyond normality: the predictive value and efficiency of medical diagnoses. New York, John Wiley & Sons, 1975:29-40.
18. Marks WH, Ohlsson K. Elimination of pancreatic secretory trypsin inhibitor from the circulation. A study in man. Scand J Gastroenterol 1983;18:955-9.
19. Tomita N, Horii A, Yamamaoto T, Ogawa M, Mori T, Matsubara K. Expression of pancreatic secretory trypsin inhibitor gene in neoplastic tissue. FEBS Lett 1987;225: 113-19.
20. Matsuda K, Ogawa M, Shibata T, et al. Postoperative elevation of serum pancreatic secretory trypsin inhibitor. Am J Gastroenterol 1985;80:694-8.
21. Stenman UH, Koivunen E, Itkonen O. Biology and function of tumor-associated trypsin inhibitor, TATI. Scand J Clin Lab Invest 1991;207:5-9.
22. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988;3: 105-12.
23. Ventrucci M, Li Bassi S, Di Grazia AM, et al. Preliminary results of a study on the exocrine pancreas in patients with end-stage renal disease maintained on hemodialysis. Ital J Gastroenterol 1992;24:174.
24. Mayer AD, McMahon MJ, Bowen M, Cooper EH. C Reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol 1984;37:207-11.
25. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34: 41-5.
26. Banks PA. Medical management of acute pancreatitis and complications. In: Go VLW, Di Magno E, Gardner JD, Lebenthal E, Reber HA, Scheele G, eds. The pancreas. Biology, pathobiology, and disease. 2nd ed. New York: Raven Press, 1993:593-611.
27. Vesentini S, Bassi C, Talamini G, Cavallini G, Campedelli A, Pederzoli P. Prospective comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg 1993;80:755-7.
28. Otsuki M, Oka T, Suehiro I, et al. Serum pancreatic secretory trypsin inhibitor in pancreatic disease. Clin Chim Acta 1984;142:231-40.
29. Kitahara T, Takatsuka Y, Fujimoto KI, Tanaka S, Ogawa M, Kosaki G. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases. Clin Chim Acta 1980;103:135-43.
30. Freeman TC, Playford RJ, Quinn C, et al. Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice. Gut 1990;31:1318-23.
31. McKeehan WL, Sakagami Y, Hoshi H, McKeenan KA. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J Biol Chem 1986;261:5378-83.
32. Higashiyama M, Monden T, Tomita N, et al. Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer. Br J Cancer 1990;62:954-8.
33. Matsuda K, Ogawa M, Murata A, Kitahara T, Kosaki G. Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases. Res Commun Chem Pathol Pharmacol 1983;40:301-5.